Increased soluble CD72 in systemic lupus erythematosus is in association with disease activity and lupus nephritis

This publication has 19 references indexed in Scilit:

• Human CD72 splicing isoform responsible for resistance to systemic lupus erythematosus regulates serum immunoglobulin level and is localized in endoplasmic reticulum
  BMC Immunology, 2012
• Human CD19+CD25high B regulatory cells suppress proliferation of CD4+ T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells
  Autoimmunity Reviews, 2012
• Peripheral blood lymphocytes analysis detects CD100/SEMA4D alteration in systemic sclerosis patients
  Autoimmunity, 2011
• CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients
  Immunity, 2010
• CD72, a Coreceptor with Both Positive and Negative Effects on B Lymphocyte Development and Function
  Journal of Clinical Immunology, 2008
• Modulation of peripheral B cell tolerance by CD72 in a murine model
  Arthritis & Rheumatism, 2008
• Down-regulation of CD72 and increased surface IgG on B cells in patients with lupus nephritis
  Autoimmunity, 2007
• Requirement for CD100–CD72 interactions in fine-tuning of B-cell antigen receptor signaling and homeostatic maintenance of the B-cell compartment
  International Immunology, 2005
• Impairment of B cell receptor-mediated Ca2+ influx, activation of mitogen-activated protein kinases and growth inhibition in CD72-deficient BAL-17 cells
  International Immunology, 2004
• CD72, a negative regulator of B‐cell responsiveness
  Immunological Reviews, 2000